novo glp-1 Nordisk Drops Hims & Hers: Inside the Compounded Crisis Novo Nordisk Reports Positive Test

Farxiga (dapagliflozin) is used in adults to: help improve blood sugar levels in certain people with type 2 diabetes, along with diet and exercise lower the risk of hospitalization or an urgent medical visit for heart failure in certain people with type 2 diabetes, heart failure, or kidney disease lower the risk of death from a heart or blood vessel problem in certain people with heart failure or long-term kidney disease help to prevent worsening kidney function in certain people with long-term kidney disease There are certain cases in which Farxiga should not be taken to treat some of these conditions

Kasagga A et al

Overall agreement 35%: A+ 10%, A 25%, A 35%, D 15%, D 15%, D+ 0%

18 There have been mixed results from published clinical studies

Quality assessment Two independent researchers analyzed the quality of eligible studies

[DOI] [PubMed] [Google Scholar] 11.Visuthranukul C., Chamni S., Kwanbunbumpen T., Saengpanit P., Chongpison Y., Tepaamorndech S., Panichsillaphakit E., Uaariyapanichkul J., Nonpat N., Chomtho S